CCR5 and melanoma: The signalling of CCL5 through CCR5 has been shown to positively regulate TGFβ, which, in turn, induces EMT through PI3k/AKT/GSK3b signalling [62], maintaining a mesenchymal phenotype and the metastatic properties of melanoma cells.